https://scholars.lib.ntu.edu.tw/handle/123456789/502829
標題: | Turning diversity toward precision | 作者: | Lin P.-Y. Chen H.-Y. SUNG-LIANG YU PAN-CHYR YANG |
公開日期: | 2017 | 卷: | 109 | 期: | 1 | 來源出版物: | Journal of the National Cancer Institute | URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/502829 | ISSN: | 0027-8874 | DOI: | 10.1093/jnci/djw238 | SDG/關鍵字: | cd109 protein; epidermal growth factor receptor; frrs1 protein; linc00941 protein; rhov protein; tumor marker; tumor protein; unclassified drug; tumor marker; cancer adjuvant therapy; cancer chemotherapy; cancer genetics; cancer immunotherapy; cancer mortality; cancer patient; cancer radiotherapy; cancer risk; cancer size; cancer staging; cancer survival; clinical practice; Editorial; gene expression; gene mutation; genetic screening; human; long term survival; lung adenocarcinoma; molecular evolution; personalized medicine; priority journal; protein function; RNA sequence; survival rate; treatment failure; whole exome sequencing; classification; genetics; high throughput sequencing; lung tumor; pathology; procedures; Biomarkers, Tumor; High-Throughput Nucleotide Sequencing; Humans; Lung Neoplasms; Precision Medicine |
顯示於: | 醫學檢驗暨生物技術學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。